RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer

The majority of breast cancer tumors are estrogen receptor-positive (ER(+)) and can be treated with endocrine therapy. However, certain patients may exhibit a good prognosis without systemic treatment. The aim of the present study was to identify novel prognostic factors for patients with ER(+) brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Fohlin, Helena, Bekkhus, Tove, Sandström, Josefine, Fornander, Tommy, Nordenskjöld, Bo, Carstensen, John, Stål, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923975/
https://www.ncbi.nlm.nih.gov/pubmed/31897114
http://dx.doi.org/10.3892/ol.2019.11109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923975/
https://www.ncbi.nlm.nih.gov/pubmed/31897114
http://dx.doi.org/10.3892/ol.2019.11109

Ejemplares similares